Why is Remedium Life falling/rising?

As of 15-Sep, Remedium Lifecare Ltd's stock price is currently at 1.52, showing no change (0.00%). The stock has performed positively in the short term, with a 5.56% increase over the past week and a 16.03% increase over the past month. However, it has significantly underperformed over the longer term, with a year-to-date decline of 57.47% and a staggering 77.67% drop over the past year. Today's price summary indicates that the stock is performing in line with its sector, but it is trading below its 200-day moving averages while being higher than its 5, 20, 50, and 100-day moving averages. Additionally, there has been a decrease in investor participation, as evidenced by a 2.32% drop in delivery volume compared to the 5-day average. The company faces significant challenges, including a high Debt to EBITDA ratio of -1.00 times, negative returns on capital employed, and a drastic decline in net sales of 76.36%, which have contributed to its poor financial performance.
In the broader market context, while the Sensex has gained 1.24% over the past week, Remedium Lifecare's stock has outperformed the benchmark during this period. However, the stock's long-term performance remains concerning, with a 77.67% decline over the past year compared to the Sensex's slight drop of 1.33%. This stark contrast highlights the company's struggles, including consecutive negative results and a lack of ability to service its debt, which raises concerns about its long-term viability. Overall, while there may be short-term gains, the underlying financial issues and poor growth prospects suggest a challenging environment for Remedium Lifecare Ltd.